Trade Summary

5 days ago, Leoni Mollie, serving as Chief Medical Officer at Kura Oncology, Inc. (KURA), sold 84,929 shares at $9.82 per share, for a total transaction value of $834,283.05. Following this transaction, Leoni Mollie now holds 182,345 shares of KURA.

This sale represents a 31.78% decrease in Leoni Mollie's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 18, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 6:00 PM ET, 4 days after the trade was made.

Kura Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.